Search results
Found 6775 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
2021 Major Educator Award winner: Oxford Simulation Teaching and Research (OxSTaR)
Members of the OxSTaR team were awarded a Major Educator Award in light of their outstanding contribution to the development of education alongside their leadership and innovation in education at both the divisional and University level.
Interviews with previous winners
Previous award winners discuss their work and the impact of winning an award.
2021 Lifetime Achievement Award Winner: Associate Professor Afsie Sabokbar
Afsie Sabokbar was one of the winners of a Lifetime Achievement Award in recognition of her unwavering commitment to providing a strong support system to enhance both student and supervisor training and development across the University.
2021 Lifetime Achievement Award Winner: Associate Professor Afsie Sabokbar
Afsie Sabokbar was one of the winners of a Lifetime Achievement Award in recognition of her unwavering commitment to providing a strong support system to enhance both student and supervisor training and development across the University.
Product design and development
In this section, you will be guided by our experts in residence, Patrick Hall (Designing Science), Kerry Briggs (Head of Medical, Kinneir Du Fort) and James Holmes (Head of Electronics, Kinneir Du Fort). You will learn how to plan ahead, improve usability and managing technical risks.
Navigating the regulatory process
Your idea for a medical device has been shown to potentially be commercially viable product, the next step is to prove your device is safe for the patient and user. In this section, Dr Toni Day, Experts in Residence at the University of Oxford, and Global Director of Quality and Regulatory Affairs at Organox, will take you on a journey through the CE Marking process to ensure you are prepared for the next step, design and development. Here we present a framework to help you navigating the regulatory process - led by Dr Toni Day, Experts in Residence at the University of Oxford, Global Director of Quality and Regulatory Affairs at Organox
Apply to give a short talk at the Oxford Metabolic Health (OMH) Symposium 2022
We are holding the fifth OMH Annual Symposium on Friday 1 July at the Medical Sciences Teaching Centre, South Parks Road.
My Favourite Failure - Video Series
Failure happens in innovation, and it’s not the end of the world. If you’re too scared of failure, you’ll never try anything new. What matters is that you learn from the experience. The problem is that the University of Oxford is built on success, so failing may be emotionally very challenging for our researchers. My favourite failure video series seeks to normalise this. We've gathered some real examples from different researchers about where things went wrong, and what the useful learning experiences were from those events.
Using data to improve transfusion practice
We will develop a fully linked electronic system from blood donor to patient, allowing us to monitor and improve the use of blood.
Clinical adoption and market access
You have now identified what your intellectual property strategy would look like, how to integrate it with your regulatory strategy and the technical development of your device. Your project development phase is progressing well and you have started the prototyping phase of your device. How can you now facilitate the transition from R&D phase to its clinical adoption and make sure your device will ultimately be used in the clinics? Our experts in residence from Odelle Technology, Deborah Rizzi, Dr Steven Haken and Claire Edwards have provided key principles that you can implement in the development phase to eliminate roadblocks to facilitate the clinical adoption of your device.
NAVIGATING INTELLECTUAL PROPERTY STRATEGY AND INVESTMENT
In this section, we will explore how you can develop your medical device so that your intellectual property strategy becomes a true asset, not a just cost, driving your project to its next step. We will discuss how investors, or companies, will look at your data, where the value of your project lies, may that be in patent, design rights or trademarks, and what components will attract investments and collaborative opportunities. Intellectual Property is a core part of any business and despite being an intangible assets has utility in many forms including; as a commercial asset, a tool from which to build and can be utilised to protect commercial value and competitive position.
Exploring the commercial opportunity of developing a medical device
You may have an idea for a medical device which is original, technically feasible and serves an unmet medical need. Unfortunately, that does not guarantee that it will be a commercially viable product. In this section, Dr Nessa Carey, Royal Society Entrepreneur in Residence at the University of Oxford, will utilise a real case study to explore the key commercial questions you need to address very early in the translation of your device idea. Here we present a case study-based exploration of key questions, led by Dr Nessa Carey, Royal Society Entrepreneur in Residence at the University of Oxford
Validation of an early biomarker of Alzheimers disease using diffusion imaging or cortical microstructure.
Transcript of an interview with Dr Steven Chance
Experts in Residence: Two Years in the Making
The Translational Research Office (TRO) has released a new brochure to highlight the success of their Experts in Residence programme.